Parkeyl acetate

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 598348

CAS#: 55570-91-7

Description: Parkeyl acetate is a bioactive chemical.


Chemical Structure

img
Parkeyl acetate
CAS# 55570-91-7

Theoretical Analysis

MedKoo Cat#: 598348
Name: Parkeyl acetate
CAS#: 55570-91-7
Chemical Formula: C32H52O2
Exact Mass: 468.40
Molecular Weight: 468.760
Elemental Analysis: C, 81.99; H, 11.18; O, 6.83

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Parkeyl acetate;

IUPAC/Chemical Name: (3S,5R,8S,10S,13R,14S,17R)-4,4,10,13,14-pentamethyl-17-((R)-6-methylhept-5-en-2-yl)-2,3,4,5,6,7,8,10,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate

InChi Key: LUYVRICDGSTYQC-ALOSQCKVSA-N

InChi Code: InChI=1S/C32H52O2/c1-21(2)11-10-12-22(3)24-15-19-32(9)26-13-14-27-29(5,6)28(34-23(4)33)17-18-30(27,7)25(26)16-20-31(24,32)8/h11,16,22,24,26-28H,10,12-15,17-20H2,1-9H3/t22-,24-,26-,27+,28+,30-,31-,32+/m1/s1

SMILES Code: CC(O[C@H]1CC[C@]2(C)C3=CC[C@]4(C)[C@@H]([C@H](C)CC/C=C(C)\C)CC[C@](C)4[C@]3([H])CC[C@]([H])2C1(C)C)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 468.76 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Hagvall L, Berglund V, Bråred Christensson J. Air-oxidized linalyl acetate - an emerging fragrance allergen? Contact Dermatitis. 2015 Apr;72(4):216-23. doi: 10.1111/cod.12350. Epub 2015 Jan 27. PubMed PMID: 25645423.

2: Ferro S, Azevedo-Silva J, Casal M, Côrte-Real M, Baltazar F, Preto A. Characterization of acetate transport in colorectal cancer cells and potential therapeutic implications. Oncotarget. 2016 Sep 21;7(43):70639-70653. doi: 10.18632/oncotarget.12156. eCollection 2016 Oct 25. PubMed PMID: 28874966; PubMed Central PMCID: PMC5342580.

3: Zeng L, Tang W, Yin J, Feng L, Li Y, Yao X, Zhou B. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells. Cell Physiol Biochem. 2016;40(3-4):453-464. Epub 2016 Nov 25. PubMed PMID: 27889747.

4: Pfortmueller CA, Fleischmann E. Acetate-buffered crystalloid fluids: Current knowledge, a systematic review. J Crit Care. 2016 Oct;35:96-104. doi: 10.1016/j.jcrc.2016.05.006. Epub 2016 May 12. Review. PubMed PMID: 27481742.

5: Chan SH, Nørregaard L, Solem C, Jensen PR. Acetate kinase isozymes confer robustness in acetate metabolism. PLoS One. 2014 Mar 17;9(3):e92256. doi: 10.1371/journal.pone.0092256. eCollection 2014. PubMed PMID: 24638105; PubMed Central PMCID: PMC3956926.

6: McKeage K. Glatiramer Acetate 40 mg/mL in Relapsing-Remitting Multiple Sclerosis: A Review. CNS Drugs. 2015 May;29(5):425-32. doi: 10.1007/s40263-015-0245-z. Review. PubMed PMID: 25906331.

7: Crowell SR, Smith JN, Creim JA, Faber W, Teeguarden JG. Physiologically based pharmacokinetic modeling of ethyl acetate and ethanol in rodents and humans. Regul Toxicol Pharmacol. 2015 Oct;73(1):452-62. doi: 10.1016/j.yrtph.2015.07.021. Epub 2015 Aug 18. PubMed PMID: 26297692.

8: Sánchez-de la Rosa R, García-Bujalance L, Meca-Lallana J. Cost analysis of glatiramer acetate versus interferon-β for relapsing-remitting multiple sclerosis in patients with spasticity: the Escala study. Health Econ Rev. 2015 Dec;5(1):30. doi: 10.1186/s13561-015-0066-2. Epub 2015 Oct 16. PubMed PMID: 26475277; PubMed Central PMCID: PMC4608957.

9: Keating GM. Eslicarbazepine acetate: a review of its use as adjunctive therapy in refractory partial-onset seizures. CNS Drugs. 2014 Jul;28(7):583-600. doi: 10.1007/s40263-014-0182-2. Review. PubMed PMID: 24972948.

10: Bhatt DP, Rosenberger TA. Acetate treatment increases fatty acid content in LPS-stimulated BV2 microglia. Lipids. 2014 Jul;49(7):621-31. doi: 10.1007/s11745-014-3911-x. Epub 2014 May 23. PubMed PMID: 24852320.

11: Atci E, Babauta JT, Sultana ST, Beyenal H. Microbiosensor for the detection of acetate in electrode-respiring biofilms. Biosens Bioelectron. 2016 Jul 15;81:517-523. doi: 10.1016/j.bios.2016.03.027. Epub 2016 Mar 15. PubMed PMID: 27016913; PubMed Central PMCID: PMC5108365.

12: Moriyama M, Kurebayashi R, Kawabe K, Takano K, Nakamura Y. Acetate Attenuates Lipopolysaccharide-Induced Nitric Oxide Production Through an Anti-Oxidative Mechanism in Cultured Primary Rat Astrocytes. Neurochem Res. 2016 Nov;41(11):3138-3146. Epub 2016 Aug 20. PubMed PMID: 27542961.

13: Ying H, Jiang H, Liu H, Chen F, Du Q. Ethyl acetate-n-butanol gradient solvent system for high-speed countercurrent chromatography to screen bioactive substances in okra. J Chromatogr A. 2014 Sep 12;1359:117-23. doi: 10.1016/j.chroma.2014.07.029. Epub 2014 Jul 18. PubMed PMID: 25069743.

14: Bergman JM, Wrande M, Hughes D. Acetate availability and utilization supports the growth of mutant sub-populations on aging bacterial colonies. PLoS One. 2014 Oct 2;9(10):e109255. doi: 10.1371/journal.pone.0109255. eCollection 2014. PubMed PMID: 25275605; PubMed Central PMCID: PMC4183559.

15: Dengler F, Rackwitz R, Benesch F, Pfannkuche H, Gäbel G. Bicarbonate-dependent transport of acetate and butyrate across the basolateral membrane of sheep rumen epithelium. Acta Physiol (Oxf). 2014 Feb;210(2):403-14. doi: 10.1111/apha.12155. Epub 2013 Aug 28. PubMed PMID: 23927569.

16: Zhang J, Zhang C, Qi Y, Dai L, Ma H, Guo X, Xiao D. Acetate ester production by Chinese yellow rice wine yeast overexpressing the alcohol acetyltransferase-encoding gene ATF2. Genet Mol Res. 2014 Nov 27;13(4):9735-46. doi: 10.4238/2014.November.27.1. PubMed PMID: 25501183.

17: Martynova J, Kokina A, Kibilds J, Liepins J, Scerbaka R, Vigants A. Effects of acetate on Kluyveromyces marxianus DSM 5422 growth and metabolism. Appl Microbiol Biotechnol. 2016 May;100(10):4585-94. doi: 10.1007/s00253-016-7392-0. Epub 2016 Feb 24. PubMed PMID: 26910042.

18: Amabebe E, Reynolds S, Stern V, Stafford G, Paley M, Anumba DO. Cervicovaginal Fluid Acetate: A Metabolite Marker of Preterm Birth in Symptomatic Pregnant Women. Front Med (Lausanne). 2016 Oct 10;3:48. eCollection 2016. PubMed PMID: 27777928; PubMed Central PMCID: PMC5056530.

19: Ando H, Kurata A, Kishimoto N. Antimicrobial properties and mechanism of volatile isoamyl acetate, a main flavour component of Japanese sake (Ginjo-shu). J Appl Microbiol. 2015 Apr;118(4):873-80. doi: 10.1111/jam.12764. Epub 2015 Feb 12. PubMed PMID: 25626919.

20: Unarokov ZM, Mukhoedova TV, Shuvaeva OV. Comparison of sustained low-efficiency dialysis with acetate-free and acetate-containing bicarbonate dialysate in unstable patients. Artif Organs. 2014 Oct;38(10):883-8. doi: 10.1111/aor.12251. Epub 2014 Jan 7. PubMed PMID: 24393008.